NASDAQ:YQ

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 17 Education & Technology Group Inc. - YQ

Retrieved on: 
Tuesday, July 26, 2022
NASDAQ, LLP, Education, News, Company, GLOBE, E&T, Pomerantz, American depositary receipt, Private investigator

NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 17 Education & Technology Group Inc. (17 E&T or the Company) (NASDAQ: YQ).

Key Points: 
  • NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 17 Education & Technology Group Inc. (17 E&T or the Company) (NASDAQ: YQ).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether 17 E&T and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for AMZN, MF, YQ: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, July 26, 2022
Time, IPO, Investment, GLOBE, Registration statement, Class, Law, Telephone, People's Law Office, Education, NASDAQ, YQ, Suite, Growth, Security (finance), Risk management, Public relations

BENSALEM, Pa., July 26, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., July 26, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Missfresh, Molecular Partners, TG Therapeutics, and 17EdTech and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, July 26, 2022

Since the IPO, the price of Missfresh's ADSs has fallen over 97%, closing at$0.3075per ADS onJuly 6, 2022.

Key Points: 
  • Since the IPO, the price of Missfresh's ADSs has fallen over 97%, closing at$0.3075per ADS onJuly 6, 2022.
  • Among other product candidates, Molecular Partners is developing ensovibep as a treatment for COVID-19 in collaboration with Novartis AG (Novartis).
  • For more information on the 17EdTech class action go to: https://bespc.com/cases/YQ
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

17 EDUCATION & TECHNOLOGY GROUP INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against 17 Education & Technology Group Inc. in the United States District Court for the Ce

Retrieved on: 
Monday, July 25, 2022
Education, Register, IPO, GLOBE, Court, ADR, Telephone, Central District, Prospectus, NASDAQ, American depositary receipt, ADR Institute of Alberta, Educational technology, YQ, District court, Investment Technology Group, Complaint, Security (finance), Public relations, Practice of law

All investors who purchased the ADRs of 17 Education & Technology Group Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased the ADRs of 17 Education & Technology Group Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com.
  • Please contact Wolf Haldenstein to learn more about your rights as an investor in the ADRs of 17 Education & Technology Group Inc.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

DEADLINE ALERT for SPRO, LMPX, MF, and YQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, July 25, 2022
Time, IPO, Investment, GLOBE, Tebipenem, Registration statement, Twitter, Law, Workforce, NDA, Income, Education, NASDAQ, Mission statement, FDA, Company, Defendant, YQ, Lists of schools in England, Complaint, Suite, Mail, Public relations

LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against 17 Education & Technology Group Inc. (YQ)

Retrieved on: 
Monday, July 25, 2022
Class Action Lawsuit, Professional Services, Legal, Time, IPO, Investment, Court, American depositary receipt, Prospectus, NASDAQ, News, Company, ADSS, Defendant, YQ, GPM, AST, Complaint, Suite, ADS, Academy, Security (finance), Animal

On December 4, 2020, 17EdTech held its IPO, selling approximately 27,400,000 American Depository Shares (ADSs) at $10.50 per ADS.

Key Points: 
  • On December 4, 2020, 17EdTech held its IPO, selling approximately 27,400,000 American Depository Shares (ADSs) at $10.50 per ADS.
  • On this news, 17EdTechs ADS price fell $3.56, or 39%, to close at $5.64 per ADS on July 23, 2021, thereby injuring investors.
  • On this news, 17EdTechs ADS price fell $1.48, or 26%, to close at $4.16 per ADS on July 26, 2021.
  • On this news, the 17EdTechs ADS price fell $0.65, or 21.3%, to close at $2.40 on June 10, 2022, thereby injuring investors further.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 17 Education & Technology Group Inc. - YQ

Retrieved on: 
Friday, July 22, 2022
NASDAQ, LLP, Education, News, Company, GLOBE, E&T, Pomerantz, American depositary receipt, Private investigator

NEW YORK, July 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 17 Education & Technology Group Inc. (17 E&T or the Company) (NASDAQ: YQ).

Key Points: 
  • NEW YORK, July 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 17 Education & Technology Group Inc. (17 E&T or the Company) (NASDAQ: YQ).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether 17 E&T and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against 17 Education & Technology Group Inc. (YQ)

Retrieved on: 
Friday, July 22, 2022
Class Action Lawsuit, Professional Services, Legal, Time, IPO, Investment, Court, Law, Telephone, American depositary receipt, Prospectus, NASDAQ, News, Company, ADSS, Defendant, YQ, AST, Complaint, Suite, ADS, Academy, Security (finance), Animal

Investors suffering losses on their 17EdTech investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .

Key Points: 
  • Investors suffering losses on their 17EdTech investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • On December 4, 2020, 17EdTech held its IPO, selling approximately 27,400,000 American Depository Shares (ADSs) at $10.50 per ADS.
  • On this news, 17EdTechs ADS price fell $3.56, or 39%, to close at $5.64 per ADS on July 23, 2021, thereby injuring investors.
  • On this news, 17EdTechs ADS price fell $1.48, or 26%, to close at $4.16 per ADS on July 26, 2021.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of 17 Education & Technology Group Inc. (YQ) Investors

Retrieved on: 
Thursday, July 21, 2022
Professional Services, Class Action Lawsuit, Time, IPO, Court, Twitter, Law, American depositary receipt, Person, Prospectus, NASDAQ, News, Company, ADSS, Defendant, YQ, AST, Complaint, Suite, ADS, Academy, Security (finance), Animal

On December 4, 2020, 17EdTech held its IPO, selling approximately 27,400,000 American Depository Shares (ADSs) at $10.50 per ADS.

Key Points: 
  • On December 4, 2020, 17EdTech held its IPO, selling approximately 27,400,000 American Depository Shares (ADSs) at $10.50 per ADS.
  • On this news, 17EdTechs ADS price fell $3.56, or 39%, to close at $5.64 per ADS on July 23, 2021, thereby injuring investors.
  • On this news, 17EdTechs ADS price fell $1.48, or 26%, to close at $4.16 per ADS on July 26, 2021.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TG Therapeutics and 17EdTech and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 21, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Death, Education, Biologics license application, Defendant, TG, IPO, Acquisition, Multiple sclerosis, GLOBE, BLA, Follicular lymphoma, Food, Shanda, American depositary receipt, Oncology Drug Advisory Committee, NDA, Risk, Lists of schools in England, Therapy, Lymphoid leukemia, Adult, New Drug Application, NASDAQ, ODAC, News, Review, SLL, FDA, Company, CLL, ADSS, Patient, YQ, Degenerative disease, Prescription Drug User Fee Act, Chronic lymphocytic leukemia, Survival, Overalls, AST, Complaint, Medical Technology Group, ADS, Academy, Pharmaceutical industry, Animal, High-performance plastics, Medical device, Security (finance), U2, P.C, Ublituximab, Umbralisib

TG Therapeutics, a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

Key Points: 
  • TG Therapeutics, a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
  • On this news, TG Therapeutics stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • On this news, TG Therapeutics stock price fell $1.93 per share, or 21.81%, to close at $6.92 per share on April 18, 2022.
  • For more information on the 17EdTech class action go to: https://bespc.com/cases/YQ
    About Bragar Eagel & Squire, P.C.